Last edition
News about "Mavacamten pediatric approval"
US FDA Approves First Drug for Rare Pediatric Heart Condition
The US FDA has approved first drug to improve functional capacity and symptoms in children with rare inherited heart condition.
Mavacamten Pediatric Approval | 03/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members